Tumor necrosis factor‐α in combination with interferon‐γ, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes
- 1 May 1990
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 20 (5) , 1131-1135
- https://doi.org/10.1002/eji.1830200528
Abstract
We have previously shown that during an infection with Leishmania major, susceptible BALB/c mice, as opposed to mice of a resistant strain (C57BL/6), are primed by lipopolysaccharide for the production of high levels of tumor necrosis factor-α (TNF-α) which is known to be a potent macrophage (MΦ) stimulator in other parasitic diseases. In the present study we investigated whether TNF-α activates MΦ for killling of L. major parasites. In the absence of interferon-γ (IFN-γ) or lipopolysaccharide, TNF-α (0.025—25000 U/ml) failed to activate peritoneal exudate MΦ from BALB/c micefor killling of L. major amastigotes. In the presence of suboptimal doses of IFN-γ (5 or 10 U/ml), however, TNF-α mediated a rapid elimination of intracellular parasites, which was highly significant compared to IFN-γ alone. The combination of TNF with interleukin 4, in contrast, was inactive in this respect and allowed survival of intracellular parasites. From these data we conclude that thepresence of IFN-γ is curcial for TNF-α-mediated killing of L. major parasites by MΦ. Disease progression in susceptible mice thereforeseems to be a consequence of a deficiency of IFN-γ and a predominance of interleukin 4 rather than the result of an excess amount of TNF-α.Keywords
This publication has 40 references indexed in Scilit:
- Macrophage activation by interferon‐γ from host‐protective T cells is inhibited by interleukin (IL) 3 and IL 4 produced by disease‐promoting T cells in leishmaniasisEuropean Journal of Immunology, 1989
- Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.The Journal of Experimental Medicine, 1989
- Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.The Journal of Experimental Medicine, 1989
- Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages.The Journal of Experimental Medicine, 1987
- Interferon γ and lymphotoxin or tumor necrosis factor act synergistically to induce macrophage killing of tumor cells and schistosomula of schistosoma mansoniThe Journal of Experimental Medicine, 1987
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Recombinant human TNF induces production of granulocyte–monocyte colony-stimulating factorNature, 1986
- Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.Journal of Clinical Investigation, 1983
- Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.The Journal of Experimental Medicine, 1983
- Studies on the mechanisms of macrophage activation. II. Parasite destruction in macrophages activated by supernates from concanavalin A-stimulated lymphocytes.The Journal of Experimental Medicine, 1979